Literature DB >> 8417847

Mechanical properties of rat cardiac skinned fibers are altered by chronic growth hormone hypersecretion.

E Mayoux1, R Ventura-Clapier, J Timsit, F Béhar-Cohen, C Hoffmann, J J Mercadier.   

Abstract

Chronic growth hormone (GH) hypersecretion in rats leads to increased isometric force without affecting the unloaded shortening velocity of isolated cardiac papillary muscles, despite a marked isomyosin shift toward V3. To determine if alterations occurred at the level of the contractile proteins in rats bearing a GH-secreting tumor (GH rats), we examined the mechanical properties of skinned fibers to eliminate the early steps of the excitation-contraction coupling mechanism. We found that maximal active tension and stiffness at saturating calcium concentrations (pCa 4.5) were markedly higher in GH rats than in control rats (tension, 52.9 +/- 5.2 versus 38.1 +/- 4.6 mN.mm-2, p < 0.05; stiffness, 1,105 +/- 120 versus 685 +/- 88 mN.mm-2.microns-1, p < 0.01), whereas values at low calcium concentrations (pCa 9) were unchanged. In addition, the calcium sensitivity of the contractile proteins was slightly but significantly higher in GH rats than in control rats (delta pCa 0.04, p < 0.001). The crossbridge cycling rate, reflected by the response to quick length changes, was lower in GH rats than in control rats (62.0 +/- 2.6 versus 77.4 +/- 6.6 sec-1, p < 0.05), in good agreement with a decrease in the proportion of alpha-myosin heavy chains in the corresponding papillary muscles (45.5 +/- 2.0% versus 94.6 +/- 2.4%, p < 0.001). The changes in myosin heavy chain protein phenotype were paralleled by similar changes of the corresponding mRNAs, indicating that the latter occurred mainly at a pretranslational level. These results demonstrate that during chronic GH hypersecretion in rats, alterations at the myofibrillar level contribute to the increase in myocardial contractility observed in intact muscle.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8417847     DOI: 10.1161/01.res.72.1.57

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  17 in total

1.  Cardiac functions in children with growth hormone deficiency before and during growth hormone-replacement therapy.

Authors:  Osman Ozdemir; Ayhan Abaci; Samil Hizli; Cem Hasan Razi; Ahmet Zulfikar Akelma; Mesut Kocak; Fatih Mehmet Kislal
Journal:  Pediatr Cardiol       Date:  2011-04-07       Impact factor: 1.655

2.  Photocontrol of the Accumulation of Plastid Polypeptides during Greening of Tomato Cotyledons : Potentiation by a Pulse of Red Light.

Authors:  Y Pauncz; S Gepstein; B A Horwitz
Journal:  Plant Physiol       Date:  1992-12       Impact factor: 8.340

3.  Differential influence of fasting and BM13.907 treatment on growth and phenotype of pressure overloaded rat heart.

Authors:  H Rupp; V Elimban; N S Dhalla
Journal:  Mol Cell Biochem       Date:  1998-11       Impact factor: 3.396

4.  The GH/IGF-1 Axis and Heart Failure.

Authors:  Graziella Castellano; Flora Affuso; Pasquale Di Conza; Serafino Fazio
Journal:  Curr Cardiol Rev       Date:  2009-08

Review 5.  Myocardial energetics and the role of micronutrients in heart failure: a critical review.

Authors:  Ang-Peng Wong; Aleksandra Niedzwiecki; Matthias Rath
Journal:  Am J Cardiovasc Dis       Date:  2016-09-15

Review 6.  Acromegalic cardiomyopathy: a review of the literature.

Authors:  M P Matta; P Caron
Journal:  Pituitary       Date:  2003       Impact factor: 4.107

Review 7.  Effects of GH and insulin-like growth factor-I on body composition.

Authors:  J Svensson; L Lönn; G Johannsson; B A Bengtsson
Journal:  J Endocrinol Invest       Date:  2003-09       Impact factor: 4.256

8.  Effects of growth hormone in rats with postinfarction left ventricular dysfunction.

Authors:  R Yang; S Bunting; N Gillett; R G Clark; H Jin
Journal:  Cardiovasc Drugs Ther       Date:  1995-02       Impact factor: 3.727

9.  Improved left ventricular function after growth hormone replacement in patients with hypopituitarism: assessment with radionuclide angiography.

Authors:  A Cuocolo; E Nicolai; A Colao; S Longobardi; S Cardei; S Fazio; B Merola; G Lombardi; L Saccà; M Salvatore
Journal:  Eur J Nucl Med       Date:  1996-04

10.  Three weekly injections (TWI) of low-dose growth hormone (GH) restore low normal circulating IGF-I concentrations and reverse cardiac abnormalities associated with adult onset GH deficiency (GHD).

Authors:  A I Pincelli; R Bragato; M Scacchi; G Branzi; G Osculati; R Viarengo; G Leonetti; F Cavagnini
Journal:  J Endocrinol Invest       Date:  2003-05       Impact factor: 4.256

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.